Icoreconnect Inc

Icoreconnect Inc. Boosts Executive Compensation with Incentive-Based Plans, Awards, and Employment Agreements

Track all markets on TradingView Icoreconnect Inc. (ICCT), a provider of cloud-based software and technology services for healthcare industries, has implemented several incentive-based plans and awards to compensate its top executives. The company aims to align executive compensation with stockholder interests and achieve a balance between long- and short-term incentives in cash and non-cash components. […]

Icoreconnect Inc. Boosts Executive Compensation with Incentive-Based Plans, Awards, and Employment Agreements Read More »

IcoreConnect’s Internal Control Weakness Puts Spotlight on Management’s Risk Oversight and Transparency as Company Continues Expansion

Track all markets on TradingView IcoreConnect Inc. (ICCT) recently disclosed in its annual Securities and Exchange Commission (SEC) report that, as of December 31, 2022, their internal control over financial reporting had not been effective due to material weakness. The company’s management has taken a proactive stance toward risk oversight, but the current situation raises

IcoreConnect’s Internal Control Weakness Puts Spotlight on Management’s Risk Oversight and Transparency as Company Continues Expansion Read More »

iCoreConnect Inc Accelerates Growth with Acquisitions in the IT Solutions Industry

Track all markets on TradingView iCoreConnect Inc (ICCT), a Nevada-based corporation, has been making significant strides in expanding its business through acquisitions in the IT solutions industry. In 2021, the company acquired three separate businesses, strengthening its position and broadening its offerings to customers. This article will take a closer look at these acquisitions and

iCoreConnect Inc Accelerates Growth with Acquisitions in the IT Solutions Industry Read More »

Icoreconnect Inc. Leverages Net Operating Loss Carryforwards to Boost Growth Opportunities in Healthcare and SaaS Markets

Track all markets on TradingView Tech-driven healthcare and software company Icoreconnect Inc. (ticker: ICCT) has experienced significant growth in recent years as a result of its strategic business expansion. With cumulative federal net operating loss carryforwards (NOLs) of approximately $18,645,000 available to be carried forward indefinitely, and federal NOLs of approximately $51,128,000 that can be

Icoreconnect Inc. Leverages Net Operating Loss Carryforwards to Boost Growth Opportunities in Healthcare and SaaS Markets Read More »

iCoreConnect Inc. Sees Intangible Assets Value Decrease, Registers Long-term Debt Growth in 2022 SEC Report

Track all markets on TradingView iCoreConnect Inc. (ticker ICCT) recently released their SEC report for the fiscal year ended December 31, 2022, which details a decrease in the value of the company’s intangible assets but a growth in long-term debt. This article will analyze the key figures presented in the report, such as the carrying

iCoreConnect Inc. Sees Intangible Assets Value Decrease, Registers Long-term Debt Growth in 2022 SEC Report Read More »

Icoreconnect Inc. Sees Operating Loss of $4.8 Million in 2022, Raising Doubts About Going Concern

Track all markets on TradingView Icoreconnect Inc. (ICCT) has recently reported an operating loss of $4.8 million for the fiscal year ending December 31, 2022. This marks a significant loss for the company, raising questions about its financial stability and future growth prospects. Operating in the North American market, Icoreconnect provides healthcare communications systems and

Icoreconnect Inc. Sees Operating Loss of $4.8 Million in 2022, Raising Doubts About Going Concern Read More »

iCoreConnect Inc. Grows Revenues with Six Primary Product Offerings for Safer and More Efficient Healthcare Services

Track all markets on TradingView INTRODUCTION iCoreConnect Inc. (ticker: ICCT) is a company specializing in software and technology solutions, particularly for the healthcare sector. As of December 31, 2022, the company has successfully introduced six primary revenue-generating services targeted at streamlining electronic prescription, insurance verification, medical coding, email encryption, analytics, and management software for healthcare

iCoreConnect Inc. Grows Revenues with Six Primary Product Offerings for Safer and More Efficient Healthcare Services Read More »

iCoreConnect Inc. Faces Substantial Doubt About Continuing as a Going Concern

Track all markets on TradingView iCoreConnect Inc, a cloud-based software and technology company, is facing substantial doubt about its ability to continue as a going concern. According to its recent SEC report, the company must raise additional funds to meet its obligations and sustain operations. This uncertain outcome has led to the company’s financial statements

iCoreConnect Inc. Faces Substantial Doubt About Continuing as a Going Concern Read More »

IcoreConnect’s Net Revenue Grows 60% in 2022, Boosted by Software Subscriptions and Asset Acquisitions

Track all markets on TradingView IcoreConnect Inc. (ticker: ICCT), a leading provider of software and managed services for the healthcare industry, posted impressive growth in the year ended December 31, 2022, according to their recently published SEC report. The company’s net revenues rose to $7,987,902 in 2022, marking a 60% increase compared to 2021’s figure

IcoreConnect’s Net Revenue Grows 60% in 2022, Boosted by Software Subscriptions and Asset Acquisitions Read More »

IcoreConnect Inc.’s Innovative Software Solutions Put the Spotlight on Data Security Amid COVID-19 Pandemic

Track all markets on TradingView As the COVID-19 pandemic continues to disrupt industries worldwide, the cloud-based software and technology company IcoreConnect Inc. (ICCT) has been working to address vulnerabilities in its software and service processes while expanding its portfolio of offerings. Capitalizing on the demand for secure and efficient solutions that protect sensitive client data,

IcoreConnect Inc.’s Innovative Software Solutions Put the Spotlight on Data Security Amid COVID-19 Pandemic Read More »